About Aptalis Products News and Events Development Pipeline Pharmaceutical Technologies Business Development Careers

Aptalis Pharma Announces Agreement to Market RECTIV(TM) in the U.S.

Aptalis Pharmaceutical Technologies

The Pharmaceutical Technology business develops and manufactures enhanced pharmaceutical products based on its broad range of proprietary oral pharmaceutical technologies.

Product Update

For More Details Click Here.

For Canada Click Here.

Quick Links

About Gastroenterology

Glossary

Aptalis Pharma Announces Agreement to Market RECTIV(TM) in the U.S.

BRIDGEWATER, NJ--(Marketwire - January 9, 2012) - Aptalis Pharma, a global specialty pharmaceutical company focused on gastrointestinal diseases and cystic fibrosis, today announced that it has signed an exclusive license agreement with ProStrakan Group plc to market RECTIV™...

Click here to read the full press release.

Site Map | Terms & Conditions | U.S. Commercial Compliance Policy | Business Ethics and Conduct Code